Document is current

Any future updates will be listed below

Treatment with ropeginterferon alfa-2b in patients with hydroxyurea resistant or intolerant polycythemia vera in South Korea: one-year results from a phase 2 study

Crossref DOI link: https://doi.org/10.1007/s44313-024-00026-6

Published Online: 2024-07-09

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark